Portfolio company
Pionyr Immunotherapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Northern Biologics
This company develops antibody-based therapeutics targeting the tumour microenvironment to treat patients with cancer and fibrosis.
Ankyra Therapeutics
This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
Profound Bio
This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.
Nectin Therapeutics
This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
Cytospire Therapeutics
This company develops multispecific immune cell engager antibodies for cancer patients to enhance and direct immune system activity against solid tumours.
